Bottom line
How much do BBH and FBTAX overlap?
35% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 65.8% of BBH's assets and 27.9% of FBTAX's. They share a meaningful core but differ in the rest of the portfolio.
FBTAX holds far more positions (129 vs 25), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and FBTAX have in common
| Holding | % of BBH | % of FBTAX | Overlap |
|---|---|---|---|
| Amgen Inc | 15.25% | 2.37% | 2.37% |
| Gilead Sciences Inc | 12.79% | 5.70% | 5.70% |
| Vertex Pharmaceuticals Inc | 9.10% | 1.39% | 1.39% |
| Revolution Medicines Inc | 5.27% | 3.00% | 3.00% |
| Argenx SE | 4.97% | 3.00% | 3.00% |
| Natera Inc | 4.92% | 1.43% | 1.43% |
| Alnylam Pharmaceuticals Inc | 3.83% | 3.62% | 3.62% |
| Biogen Inc | 3.63% | 2.71% | 2.71% |
| Moderna Inc | 3.36% | 1.60% | 1.60% |
| Insmed Inc | 2.67% | 3.05% | 2.67% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Regeneron Pharmaceuticals Inc — 6.21%
- IQVIA Holdings Inc — 4.31%
- Illumina Inc — 3.17%
- United Therapeutics Corp — 2.83%
- BeOne Medicines Ltd — 2.81%
- Incyte Corp — 2.49%
- Neurocrine Biosciences Inc — 2.08%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Bio-Techne Corp — 1.54%
- Charles River Laboratories International Inc — 1.50%
- BioMarin Pharmaceutical Inc — 1.34%
- Qiagen Nv — 1.06%
- Tempus AI Inc — 0.98%
- State Street Global Advisors — 0.06%
Only in FBTAX
- Abbvie Inc — 14.71%
- Spyre Therapeutics Inc — 3.83%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Ascendis Pharma A/s — 2.99%
- Mbx Biosciences Inc — 2.45%
- Amylyx Pharmaceuticals Inc — 2.25%
- Vaxcyte Inc — 1.97%
- Fidelity Revere Street Trust — 1.96%
- Relay Therapeutics Inc — 1.58%
- Viridian Therapeutics Inc — 1.53%
- Kiniksa Pharmaceuticals International Plc — 1.41%
- Enliven Therapeutics Inc — 1.25%
- Alumis Inc — 1.22%
Asset mix
| Asset type | BBH | FBTAX |
|---|---|---|
| Stocks | 100.0% | 98.2% |
| Cash & short-term funds | 0.1% | 2.4% |
| Preferred stock | — | 1.5% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | BBH | FBTAX |
|---|---|---|
| US | 87.3% | 87.8% |
| NL | 6.0% | 4.3% |
| DK | — | 3.0% |
| CH | 2.8% | — |
| DE | 1.9% | 0.1% |
| IE | 1.9% | — |
| KY | — | 1.8% |
| GB | — | 1.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do BBH and FBTAX overlap?
What stocks do BBH and FBTAX have in common?
Should I own both BBH and FBTAX?
Which holds more stocks, BBH or FBTAX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.